Reduction in circulating vitamin D binding protein in patients with multiple sclerosis
Abstract Background In this study, we aimed to determine the risk association between vitamin D binding protein (VDBP) polymorphism in patients with multiple sclerosis (MS) in a MS biobank and the difference in VDBP serum levels in MS patients who were recently diagnosed. Method The current case-con...
Main Authors: | Zhila Maghbooli, Abolfazl Omidifar, Tarlan Varzandi, Tayebeh Salehnezhad, Mohammad Ali Sahraian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12883-021-02200-0 |
Similar Items
-
Alterations in circulating levels of vitamin D binding protein, total and bioavailability of vitamin D in diabetic retinopathy patients
by: Ebrahimi Meimand, S., et al.
Published: (2022) -
Increased Circulating Levels of Vitamin D Binding Protein in MS Patients
by: Arturo Ottavio Rinaldi, et al.
Published: (2015-01-01) -
Assessment of vitamin D-binding protein (DBP) gene polymorphisms and their correlation with multiple sclerosis: a case-control study in a sample of the Syrian population
by: Bushra Alhomsi, et al.
Published: (2020-08-01) -
Comparison of Vitamin D3 Serum Levels in New Diagnosed Patients with Multiple Sclerosis versus Their Healthy Relatives
by: Hamidreza Abbasi, et al.
Published: (2013-05-01) -
Comparison of Vitamin D3 Serum Levels in New Diagnosed Patients with Multiple Sclerosis versus Their Healthy Relatives
by: Mehrdokht Mazdeh, et al.
Published: (2013-05-01)